Background: Fas ligand (FasL, CD95L) predominantly expressed on activated c
ytotoxic T cells and NK cells triggers apoptosis in Fas receptor (Apo-1, CD
95),positive target cells. We investigated the expression of Fast, I:as and
tumor necrosis factor (TNF) receptor 1 (TNF-R1, CD120a) on cultured human
lymphocytes and leukemic T and B cells. Materials and Methods: Lymphocytes
from six healthy individuals, from four patients with chronic lymphocytic T
or B cell leukaemia, and leukemic Molt-4 cells were incubated with the apo
ptosis- inducing mistletoe lectins (ML I and ML III). Results: Incubation o
f differentiated lymphocytes with the ML resulted in a significant upregula
tion of Fast in the surviving CD4(+) T helper cells, CD8(+) cells and CD19(
+) B cells. Similarly, the TNF receptor expression increased, while the Fas
molecule decreased. In contrast, Fast was not induced in leukemic cells. C
onclusions: Apart from a direct induction of apoptosis in response to an in
hibition of protein synthesis by the enzymic ML A chain, ML treatment may i
ndirectly induce apoptosis in Fas(+) tumour cells through activated FasL(+)
lymphocytes.